Miriam Möller

4PUBLICATIONS
4CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 14, 2025
Real-World Outcomes of Chemoradiotherapy in Patients with Stage II/III Non-Small-Cell Lung Cancer in the Durvalumab Era: An Observational Study.

Jörg Andreas Müller, Jonas Buchberger, Elias Schmidt-Riese

|Oct 14, 2023
Blood Immune Cells as Biomarkers in Long-Term Surviving Patients with Advanced Non-Small-Cell Lung Cancer Undergoing a Combined Immune/Chemotherapy.

Miriam Möller, Wolfgang Schütte, Steffi Turzer

|Feb 25, 2023
Monitoring Blood Immune Cells in Patients with Advanced Small Cell Lung Cancer Undergoing a Combined Immune Checkpoint Inhibitor/Chemotherapy.

Dagmar Riemann, Steffi Turzer, Georgi Ganchev

|Nov 10, 2022
Retrospective Data Analysis of Patients With Metastatic Lung Adenocarcinoma With or Without KRAS-Mutation or TTF1-Expression.

Miriam Moeller, Florian Schaedlich, Wolfgang Schuette

Pageof 1

Frequent Collaborators

2 joint publications

Dagmar Riemann

2 joint publications

Barbara Seliger

1 joint publications

Jörg Andreas Müller

1 joint publications

Clara Pitzschel